Earnings Call · Q1 FY2022·2022-05-07

Q1 22EPS -2.78%·Rev n/aQ4 21EPS -42.86%·Rev n/aQ3 21EPS -16.67%·Rev n/aQ2 21EPS +3.23%·Rev n/a⚠ consensus missing

CytomX Therapeutics, Inc. CTMX

Chau Cheng — Vice President, Investor Relations

Sean McCarthy — Chief Executive Officer and Chairman

Amy Peterson — President and Chief Operating Officer

Carlos Campoy — Chief Financial Officer

+0.6%1d on move date+1.2% vs SPY3d+10.6%5d+8.1%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CTMX calls or request research access.

More CTMX calls Browse calls Request research access